Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
or

Azenta Inc (AZTA)

Azenta Inc (AZTA)
15.30 x 2 49.46 x 1
Post-market by (Cboe BZX)
38.23 +0.80 (+2.14%) 03/24/25 [NASDAQ]
15.30 x 2 49.46 x 1
Post-market 37.71 -0.52 (-1.36%) 16:01 ET
Quote Overview for Mon, Mar 24th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
37.63
Day High
38.57
Open 37.82
Previous Close 37.43 37.43
Volume 438,000 438,000
Avg Vol 770,740 770,740
Stochastic %K 23.28% 23.28%
Weighted Alpha -38.83 -38.83
5-Day Change +0.76 (+2.03%) +0.76 (+2.03%)
52-Week Range 35.56 - 63.58 35.56 - 63.58
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,746,958
  • Shares Outstanding, K 45,696
  • Annual Sales, $ 656,320 K
  • Annual Income, $ -164,170 K
  • EBIT $ -69 M
  • EBITDA $ 131 M
  • 60-Month Beta 1.52
  • Price/Sales 2.61
  • Price/Cash Flow 8.31
  • Price/Book 1.00

Options Overview Details

View History
  • Implied Volatility 50.25% ( -6.31%)
  • Historical Volatility 56.43%
  • IV Percentile 45%
  • IV Rank 41.83%
  • IV High 77.11% on 04/18/24
  • IV Low 30.94% on 08/30/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 23
  • Put/Call OI Ratio 2.50
  • Today's Open Interest 4,300
  • Open Int (30-Day) 4,357

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 0.09
  • Number of Estimates 2
  • High Estimate 0.09
  • Low Estimate 0.09
  • Prior Year 0.05
  • Growth Rate Est. (year over year) +80.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
35.56 +7.51%
on 03/18/25
Period Open: 45.58
47.55 -19.60%
on 02/26/25
-7.35 (-16.13%)
since 02/24/25
3-Month
35.56 +7.51%
on 03/18/25
Period Open: 50.25
55.63 -31.28%
on 02/06/25
-12.02 (-23.92%)
since 12/24/24
52-Week
35.56 +7.51%
on 03/18/25
Period Open: 59.31
63.58 -39.87%
on 07/31/24
-21.08 (-35.54%)
since 03/22/24

Most Recent Stories

More News
Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

Drug Development Inputs & Services Stocks Q4 In Review: Medpace (NASDAQ:MEDP) Vs Peers

MEDP : 330.59 (+1.96%)
FTRE : 9.40 (+7.18%)
AZTA : 38.23 (+2.14%)
RGEN : 145.15 (+3.66%)
CRL : 166.98 (-0.18%)
Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

Drug Development Inputs & Services Stocks Q4 Results: Benchmarking Fortrea (NASDAQ:FTRE)

FTRE : 9.40 (+7.18%)
MEDP : 330.59 (+1.96%)
AZTA : 38.23 (+2.14%)
WST : 231.90 (+1.41%)
IQV : 186.11 (+0.12%)
Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

Unpacking Q4 Earnings: UFP Technologies (NASDAQ:UFPT) In The Context Of Other Drug Development Inputs & Services Stocks

FTRE : 9.40 (+7.18%)
UFPT : 210.50 (+5.86%)
AZTA : 38.23 (+2.14%)
WST : 231.90 (+1.41%)
CRL : 166.98 (-0.18%)
Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

Q4 Earnings Recap: Azenta (NASDAQ:AZTA) Tops Drug Development Inputs & Services Stocks

FTRE : 9.40 (+7.18%)
UFPT : 210.50 (+5.86%)
AZTA : 38.23 (+2.14%)
RGEN : 145.15 (+3.66%)
WST : 231.90 (+1.41%)
1 Small-Cap Stock with Exciting Potential and 2 to Brush Off

1 Small-Cap Stock with Exciting Potential and 2 to Brush Off

DY : 161.57 (+3.41%)
SLGN : 50.08 (+0.62%)
AZTA : 38.23 (+2.14%)
A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

A Look Back at Drug Development Inputs & Services Stocks’ Q4 Earnings: Repligen (NASDAQ:RGEN) Vs The Rest Of The Pack

FTRE : 9.40 (+7.18%)
MEDP : 330.59 (+1.96%)
RGEN : 145.15 (+3.66%)
AZTA : 38.23 (+2.14%)
IQV : 186.11 (+0.12%)
Is the Options Market Predicting a Spike in Azenta (AZTA) Stock?

Investors in Azenta, Inc. AZTA need to pay close attention to the stock based on moves in the options market lately. That is because the Dec. 19, 2025 $22.5 Call had some of the highest implied volatility...

AZTA : 38.23 (+2.14%)
Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

Spotting Winners: Charles River Laboratories (NYSE:CRL) And Drug Development Inputs & Services Stocks In Q4

FTRE : 9.40 (+7.18%)
MEDP : 330.59 (+1.96%)
AZTA : 38.23 (+2.14%)
CRL : 166.98 (-0.18%)
IQV : 186.11 (+0.12%)
What To Expect From Fortrea’s (FTRE) Q4 Earnings

What To Expect From Fortrea’s (FTRE) Q4 Earnings

FTRE : 9.40 (+7.18%)
UFPT : 210.50 (+5.86%)
AZTA : 38.23 (+2.14%)
UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

UFP Technologies (UFPT) Reports Q4: Everything You Need To Know Ahead Of Earnings

UFPT : 210.50 (+5.86%)
AZTA : 38.23 (+2.14%)
CRL : 166.98 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Azenta Inc. is a provider of life sciences solutions. The company provides reliable cold-chain sample management solutions and genomic services across areas such as drug development, clinical research and advanced cell therapies for the pharmaceutical, biotech, academic and healthcare institutions. Azenta...

See More

Key Turning Points

3rd Resistance Point 39.60
2nd Resistance Point 39.09
1st Resistance Point 38.66
Last Price 38.23
1st Support Level 37.71
2nd Support Level 37.20
3rd Support Level 36.77

See More

52-Week High 63.58
Fibonacci 61.8% 52.88
Fibonacci 50% 49.57
Fibonacci 38.2% 46.26
Last Price 38.23
52-Week Low 35.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals